What is the initial management of a patient with propranolol overdose who presents with symptomatic bradycardia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Propranolol Overdose with Bradycardia

Glucagon 50-150 mcg/kg IV bolus followed by continuous infusion at 1-5 mg/hour is the first-line antidote for propranolol-induced bradycardia and hypotension, as it bypasses beta-receptor blockade to exert direct inotropic and chronotropic effects. 1

Immediate Assessment and Stabilization

  • Assess for signs of hemodynamic compromise including altered mental status, hypotension (systolic BP <80-90 mmHg), acute heart failure, or shock—these indicate life-threatening toxicity requiring immediate intervention. 2
  • Maintain airway patency and assist ventilation if needed, provide supplemental oxygen if hypoxemic, establish cardiac monitoring, obtain IV access, and perform 12-lead ECG. 2
  • If ingestion was recent (within 1-2 hours), perform gastric lavage taking care to prevent pulmonary aspiration, followed by activated charcoal administration. 1, 3

First-Line Antidote: Glucagon

  • Administer glucagon 50-150 mcg/kg (typically 3-10 mg) as IV bolus over 1-2 minutes, as this is the FDA-recommended first-line treatment for propranolol overdose with superior efficacy compared to atropine or catecholamines. 1
  • Follow the bolus immediately with continuous glucagon infusion at 1-5 mg/hour, titrating to achieve adequate heart rate (target ≥60 bpm) and blood pressure (systolic ≥90 mmHg). 1
  • Glucagon works by activating adenylyl cyclase independent of beta-receptors, producing positive inotropic and chronotropic effects even when beta-receptors are completely blocked. 1, 4
  • Monitor for glucagon-induced nausea and vomiting; have suction readily available to prevent aspiration. 4

Second-Line Pharmacologic Interventions

If Bradycardia Persists Despite Glucagon

  • Atropine 0.5-1 mg IV may be attempted (repeat every 3-5 minutes up to maximum 3 mg total), though it is often ineffective in propranolol overdose because the bradycardia results from direct myocardial depression rather than vagal tone. 1, 2
  • Isoproterenol infusion 2-10 mcg/min can be used for refractory bradycardia, as it provides direct beta-agonist effects that may partially overcome receptor blockade at high doses. 1
  • Transcutaneous pacing should be initiated immediately if pharmacologic measures fail to restore adequate heart rate in hemodynamically unstable patients, serving as a bridge to transvenous pacing if needed. 2

If Hypotension Persists Despite Glucagon

  • Dopamine 5-20 mcg/kg/min IV infusion provides both inotropic and vasopressor effects, though response may be blunted due to beta-receptor blockade. 1, 3
  • Avoid epinephrine as it may provoke uncontrolled hypertension due to unopposed alpha-adrenergic stimulation when beta-receptors are blocked. 1
  • Norepinephrine 0.1-0.5 mcg/kg/min may be more effective than dopamine for severe hypotension, providing alpha-mediated vasoconstriction. 3

Advanced Rescue Therapies for Refractory Shock

High-Dose Insulin Euglycemia (HIE) Therapy

  • Initiate insulin infusion at 1 unit/kg/hour IV with concurrent dextrose 0.5 g/kg/hour (typically D50W at 25-50 mL/hour) to maintain euglycemia (glucose 100-200 mg/dL) in patients with cardiogenic shock unresponsive to glucagon and vasopressors. 3
  • Insulin enhances myocardial contractility by improving calcium handling and myocardial glucose uptake, independent of beta-receptors. 3
  • Monitor blood glucose every 15-30 minutes initially, then hourly once stable; monitor potassium every 2 hours and replace aggressively (target K+ 4-5 mEq/L). 3
  • Continue HIE therapy for 24-48 hours or until hemodynamic stability is achieved and propranolol levels decline. 3

Intravenous Lipid Emulsion (ILE) Therapy

  • Administer 20% lipid emulsion 1.5 mL/kg IV bolus over 1 minute (typically 100 mL for 70 kg patient) for cardiac arrest or severe refractory shock despite glucagon and HIE. 3
  • Follow with continuous infusion at 0.25 mL/kg/min (approximately 400 mL over 30-60 minutes), and repeat bolus after 5 minutes if cardiac arrest persists. 3
  • Lipid emulsion creates an intravascular "lipid sink" that sequesters lipophilic propranolol, reducing free drug concentration at cardiac tissue. 3
  • Maximum recommended dose is 10 mL/kg over the first 30 minutes; monitor for lipemia and pancreatitis. 3

Mechanical Circulatory Support

  • Intra-aortic balloon pump (IABP) or veno-arterial extracorporeal membrane oxygenation (VA-ECMO) should be considered for refractory cardiogenic shock or cardiac arrest requiring prolonged CPR (>30-60 minutes) despite maximal pharmacologic therapy. 5, 6
  • IABP provides hemodynamic support by augmenting diastolic blood pressure and reducing afterload, serving as a bridge to recovery as propranolol is metabolized. 5
  • VA-ECMO via femoral vein-femoral artery cannulation provides complete cardiopulmonary support and has successfully rescued patients with massive propranolol overdose unresponsive to all other measures. 6

Management of Specific Complications

Seizures

  • Administer benzodiazepines (lorazepam 2-4 mg IV or diazepam 5-10 mg IV) as first-line treatment for propranolol-induced seizures, which result from CNS toxicity due to propranolol's high lipophilicity. 7
  • Seizures indicate severe toxicity and are associated with poor prognosis, particularly when combined with cardiac arrest. 7

Bronchospasm

  • Treat with isoproterenol or aminophylline rather than standard beta-agonist bronchodilators, which will be ineffective due to beta-receptor blockade. 1
  • Aminophylline 6 mg/kg IV over 20-30 minutes provides bronchodilation through phosphodiesterase inhibition. 2

Monitoring and Disposition

  • Continuously monitor ECG, blood pressure, oxygen saturation, and neurological status throughout treatment. 1
  • Measure serum propranolol levels if available, though management is guided by clinical response rather than specific levels. 3
  • All patients with propranolol overdose require ICU admission for continuous cardiac monitoring and potential need for advanced interventions. 2
  • Propranolol has a half-life of 3-6 hours, but clinical effects may persist 12-24 hours or longer in massive overdose; continue supportive care and monitoring until complete resolution. 7

Critical Pitfalls to Avoid

  • Do not delay glucagon administration while attempting atropine or standard vasopressors—glucagon is the specific antidote and should be given immediately. 1, 4
  • Do not use epinephrine for hypotension as it may cause severe hypertension due to unopposed alpha effects. 1
  • Do not assume neurological findings (including unreactive pupils) indicate irreversible brain injury—these may be drug effects and can completely resolve with supportive care. 6
  • Time from ingestion to treatment is the most critical prognostic factor—patients presenting within 1-2 hours have significantly better outcomes than those with delayed presentation. 7
  • Cardiac arrest within the first hour post-ingestion indicates massive overdose (typically >4-8 grams) and requires immediate aggressive intervention including consideration of mechanical circulatory support. 5, 7

Related Questions

What physical symptoms occur with a propranolol overdose?
What are the initial and subsequent steps in managing a propranolol (propranolol hydrochloride) overdose?
What are the physical symptoms of a propranolol (propranolol hydrochloride) overdose?
Can ingesting 1g of propranolol (a beta blocker) be fatal?
What is the antidote for propranolol (beta blocker) overdose?
In a patient with polymyositis presenting with bluish discoloration of the toes, what does this signify and how should it be evaluated and managed?
What are the diagnostic changes for Obsessive‑Compulsive Disorder (OCD) across DSM‑III (Diagnostic and Statistical Manual of Mental Disorders, third edition), DSM‑III‑R (Text Revision), DSM‑IV (fourth edition), DSM‑5 (fifth edition), DSM‑5‑TR (Text Revision), ICD‑10 (International Classification of Diseases, tenth revision), and ICD‑11 (eleventh revision)?
What is the appropriate dose of Fluvir (oseltamivir) syrup for a 4‑month‑old infant weighing 3.9 kg?
What is the recommended approach to wean a patient from mechanical ventilation?
What is the efficacy of palivizumab in preventing RSV‑related hospitalizations in high‑risk infants under 24 months (e.g., preterm, chronic lung disease of prematurity, congenital heart disease)?
What are the strengths and weaknesses of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM‑5‑TR) and the International Classification of Diseases, Eleventh Revision (ICD‑11) for diagnosing obsessive‑compulsive disorder?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.